FDA
-
-
-
-
-
-
-
Longeveron receives committee approval to complete stem cell trial
-
-
-
-
-
-
-
Longeveron to Report 2025 Full-Year Financial Results and Host Conference Call on March 17, 2026
-
-
-
-
-
-
-
Longeveron appoints Stephen Willard as CEO
-
-
-
-
-
-
-
Longeveron, Selected as a StartUp Health Alzheimer’s Disease Moonshot Company, Will Participate in StartUp Health Apollo House During JPM Healthcare Week 2026
-
-
-
-
-
-
-
Longeveron presents MRI data on stem cell therapy for Alzheimer's
-
-
-
-
-
-
-
Longeveron® to Report Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025
-
-
-
-
-
-
-
Longeveron® Announces Key Leadership Updates
-
322,981 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

